• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统评价和荟萃分析左炔诺孕酮宫内缓释系统降低卵巢癌风险的影响。

Systematic review and meta-analysis on the impact of the levonorgestrel-releasing intrauterine system in reducing risk of ovarian cancer.

机构信息

Academic Unit of Obstetrics and Gynecology, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genova, Genova, Italy.

出版信息

Int J Gynaecol Obstet. 2022 Mar;156(3):418-424. doi: 10.1002/ijgo.13737. Epub 2021 Jun 8.

DOI:10.1002/ijgo.13737
PMID:33969485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9290617/
Abstract

BACKGROUND

Ovarian carcinoma (OC) is one of the most widespread tumors in the world and is characterized by low survival rates.

OBJECTIVE

To determine whether the levonorgestrel-releasing intrauterine system (LNG-IUS) can prevent OC.

SEARCH STRATEGY

The literature until December 2020 were systematically reviewed according to the PRISMA Statement for Reporting Systematic Reviews (PROSPERO: CRD42019137957).

SELECTION CRITERIA

Studies assessing the impact of LNG-IUS on the risk of OC were included.

DATA COLLECTION AND ANALYSIS

Data were extracted independently by two authors to ensure accuracy and consistency.

MAIN RESULTS

A total of 34 323 records were obtained, of which three satisfied the inclusion criteria. In total, 1687 events of OC in a population of 20 461 311 person-years were considered. Data pooling revealed that the use of LNG-IUS did not confer a lower risk of OC relative to the never-use of LNG-IUS, with an estimated odds ratio of 0.66 (95% confidence interval 0.41-1.08; I = 84%; P = 0.002).

CONCLUSION

The meta-analysis did not demonstrate a preventive role of LNG-IUS on OC. However, it was carried out on a few papers, and a definitive conclusion on the topic still cannot be drawn. Further studies are indicated in the future to define the impact of LNG-IUS on OC. The meta-analysis carried out on three papers did not demonstrate a preventive role of the levonorgestrel-releasing intrauterine device on ovarian cancer.

摘要

背景

卵巢癌(OC)是世界上最广泛的肿瘤之一,其特征是生存率低。

目的

确定左炔诺孕酮释放宫内节育系统(LNG-IUS)是否可以预防 OC。

搜索策略

根据 PRISMA 声明(PROSPERO:CRD42019137957)系统地回顾了截至 2020 年 12 月的文献。

选择标准

包括评估 LNG-IUS 对 OC 风险影响的研究。

数据收集和分析

两名作者独立提取数据,以确保准确性和一致性。

主要结果

共获得 34323 条记录,其中 3 条符合纳入标准。共考虑了 20461311 人年的人群中 1687 例 OC 事件。数据合并显示,与从未使用 LNG-IUS 相比,使用 LNG-IUS 并不能降低 OC 的风险,估计比值比为 0.66(95%置信区间 0.41-1.08;I = 84%;P = 0.002)。

结论

荟萃分析并未显示 LNG-IUS 对 OC 有预防作用。然而,它是基于少数几篇论文进行的,因此仍然无法得出关于该主题的明确结论。未来需要进一步的研究来确定 LNG-IUS 对 OC 的影响。对三篇论文的荟萃分析并未显示左炔诺孕酮释放宫内节育器对卵巢癌有预防作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24df/9290617/83ea955b1fa5/IJGO-156-418-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24df/9290617/8a9f7a2edbdd/IJGO-156-418-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24df/9290617/83ea955b1fa5/IJGO-156-418-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24df/9290617/8a9f7a2edbdd/IJGO-156-418-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24df/9290617/83ea955b1fa5/IJGO-156-418-g002.jpg

相似文献

1
Systematic review and meta-analysis on the impact of the levonorgestrel-releasing intrauterine system in reducing risk of ovarian cancer.系统评价和荟萃分析左炔诺孕酮宫内缓释系统降低卵巢癌风险的影响。
Int J Gynaecol Obstet. 2022 Mar;156(3):418-424. doi: 10.1002/ijgo.13737. Epub 2021 Jun 8.
2
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.用于治疗月经过多的孕激素或释放孕激素的宫内节育系统。
Cochrane Database Syst Rev. 2005 Oct 19(4):CD002126. doi: 10.1002/14651858.CD002126.pub2.
3
Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.左炔诺孕酮宫内节育器(LNG-IUD)用于手术后有症状的子宫内膜异位症。
Cochrane Database Syst Rev. 2006 Oct 18(4):CD005072. doi: 10.1002/14651858.CD005072.pub2.
4
Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy.激素浸渍宫内节育系统(IUSs)与其他形式的可逆性避孕方法作为预防妊娠的有效方法。
Cochrane Database Syst Rev. 2004;2004(3):CD001776. doi: 10.1002/14651858.CD001776.pub2.
5
Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.左炔诺孕酮宫内节育系统(LNG-IUD)治疗手术后症状性子宫内膜异位症。
Cochrane Database Syst Rev. 2021 Dec 20;12(12):CD005072. doi: 10.1002/14651858.CD005072.pub4.
6
Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding.含孕激素宫内节育系统与安慰剂或其他药物治疗月经过多的比较
Cochrane Database Syst Rev. 2000(2):CD002126. doi: 10.1002/14651858.CD002126.
7
Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy.激素浸渍宫内节育系统(IUSs)与其他形式的可逆性避孕方法相比,是预防妊娠的有效方法。
Cochrane Database Syst Rev. 2001(2):CD001776. doi: 10.1002/14651858.CD001776.
8
Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis.干预重度月经过多;Cochrane 综述和网络荟萃分析概述。
Cochrane Database Syst Rev. 2022 May 31;5(5):CD013180. doi: 10.1002/14651858.CD013180.pub2.
9
Influence of the levonorgestrel-releasing intrauterine system on the risk of breast cancer: a systematic review.左炔诺孕酮宫内缓释系统对乳腺癌风险的影响:系统评价。
Arch Gynecol Obstet. 2023 Jun;307(6):1747-1761. doi: 10.1007/s00404-022-06640-y. Epub 2022 Jun 18.
10
Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine-device use.预防或治疗宫内节育器使用相关的月经过多或疼痛的干预措施。
Cochrane Database Syst Rev. 2022 Aug 26;8(8):CD006034. doi: 10.1002/14651858.CD006034.pub3.

引用本文的文献

1
Incessant ovulation: a review of its importance in predicting cancer risk.持续排卵:关于其在预测癌症风险中重要性的综述
Front Oncol. 2023 Oct 6;13:1240309. doi: 10.3389/fonc.2023.1240309. eCollection 2023.
2
Executive Summary of the Ovarian Cancer Evidence Review Conference.卵巢癌证据审查会议执行摘要。
Obstet Gynecol. 2023 Jul 1;142(1):179-195. doi: 10.1097/AOG.0000000000005211. Epub 2023 Jun 7.
3
Influence of the levonorgestrel-releasing intrauterine system on the risk of breast cancer: a systematic review.左炔诺孕酮宫内缓释系统对乳腺癌风险的影响:系统评价。

本文引用的文献

1
Obstetric outcomes after uterus-sparing surgery for uterine prolapse: A systematic review and meta-analysis.子宫脱垂保留子宫手术后的产科结局:一项系统评价和荟萃分析。
Eur J Obstet Gynecol Reprod Biol. 2021 Jan;256:333-338. doi: 10.1016/j.ejogrb.2020.11.054. Epub 2020 Nov 20.
2
Ever-use of the intra-uterine device and the risk of ovarian cancer.宫内节育器的长期使用与卵巢癌风险。
J Obstet Gynaecol. 2021 Aug;41(6):848-853. doi: 10.1080/01443615.2020.1789960. Epub 2020 Oct 12.
3
Female Genital Hair-Thread Tourniquet Syndrome: A Case Report and Literature Systematic Review.
Arch Gynecol Obstet. 2023 Jun;307(6):1747-1761. doi: 10.1007/s00404-022-06640-y. Epub 2022 Jun 18.
女性生殖器毛发绞勒止血带综合征:病例报告及文献系统评价。
J Pediatr Adolesc Gynecol. 2021 Feb;34(1):65-70. doi: 10.1016/j.jpag.2020.07.007. Epub 2020 Jul 18.
4
Intrauterine Device Use and Ovarian Cancer Risk: A Systematic Review and Meta-analysis.宫内节育器使用与卵巢癌风险:系统评价和荟萃分析。
Obstet Gynecol. 2019 Oct;134(4):791-800. doi: 10.1097/AOG.0000000000003463.
5
Long-term effects of episiotomy on urinary incontinence and pelvic organ prolapse: a systematic review.会阴切开术对尿失禁和盆腔器官脱垂的长期影响:系统评价。
Arch Gynecol Obstet. 2019 Feb;299(2):317-325. doi: 10.1007/s00404-018-5009-9. Epub 2018 Dec 18.
6
Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.丹麦一项针对生育年龄妇女的前瞻性全国队列研究:当代激素避孕与卵巢癌的关联。
BMJ. 2018 Sep 26;362:k3609. doi: 10.1136/bmj.k3609.
7
Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study.左炔诺孕酮宫内节育系统的使用与降低卵巢癌和子宫内膜癌的风险有关,而不会增加乳腺癌的风险。NOWAC 研究的结果。
Gynecol Oncol. 2018 Apr;149(1):127-132. doi: 10.1016/j.ygyno.2018.02.006. Epub 2018 Mar 2.
8
Fetal Tricuspid Regurgitation in the First Trimester as a Screening Marker for Congenital Heart Defects: Systematic Review and Meta-Analysis.孕早期胎儿三尖瓣反流作为先天性心脏病筛查标志物的系统评价和荟萃分析
Fetal Diagn Ther. 2017;42(1):1-8. doi: 10.1159/000455947. Epub 2017 May 9.
9
Minimally Invasive Surgical Staging in Early-stage Ovarian Carcinoma: A Systematic Review and Meta-analysis.早期卵巢癌的微创外科分期:一项系统评价和荟萃分析
J Minim Invasive Gynecol. 2017 May-Jun;24(4):552-562. doi: 10.1016/j.jmig.2017.02.013. Epub 2017 Feb 20.
10
Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube.左炔诺孕酮宫内节育系统的使用对卵巢和输卵管癌症风险的影响。
Acta Oncol. 2016 Nov;55(11):1281-1284. doi: 10.1080/0284186X.2016.1175660. Epub 2016 May 5.